Bcl-2 expression in rectal cancer

Arq Gastroenterol. 2006 Oct-Dec;43(4):284-7. doi: 10.1590/s0004-28032006000400008.

Abstract

Background: [corrected] Proteins involved in apoptosis process seem to play an important role in colorectal carcinogenesis

Aim: To determine the prevalence of bcl-2 protein immunohistochemical expression and its relation with clinical and histopathological variables of rectal adenocarcinoma.

Patients and methods: One hundred and thirty-two patients operated at "Hospital de Clínicas de Porto Alegre", Porto Alegre, RS, Brazil, between 1988 and 1999 were studied through immunohistochemical reaction using a monoclonal antibody anti-bcl-2 on formalin-fixed, paraffin-embedded tissue samples

Results: The prevalence of bcl-2 protein was 29.5%. There was a significant increased number of positive bcl-2 cases among women as compared to men. There was no significant association between bcl-2 and age, tumour site, histological grade, mucin production, depth of invasion, lymphatic involvement, distant metastasis or stage, despite a trend showing decreased immunoreactivity to bcl-2 among poorly and moderately differentiated tumours, as well as disseminated disease

Conclusions: Analysis of bcl-2 protein expression in tumour tissues, as well as other oncoproteins, may have a role in predict therapeutic response and prognosis of colorectal cancer. However, the potential use of bcl-2 protein assessment in the clinical set for management of rectal cancer remains to be determined.

MeSH terms

  • Adenocarcinoma / chemistry*
  • Adenocarcinoma / pathology
  • Adult
  • Aged
  • Aged, 80 and over
  • Apoptosis
  • Biomarkers, Tumor / analysis*
  • Cell Survival
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Proto-Oncogene Proteins c-bcl-2 / analysis*
  • Rectal Neoplasms / chemistry*
  • Rectal Neoplasms / pathology
  • Retrospective Studies

Substances

  • Biomarkers, Tumor
  • Proto-Oncogene Proteins c-bcl-2